McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers... Show more
McKesson (MCK) maintains a conservative dividend policy focused on sustainable growth rather than high current income. The company pays dividends quarterly, with payments historically scheduled in January, April, July, and October. The trailing twelve-month dividend yield is approximately 0.38%, based on an annualized payout of $3.28 per share. This modest yield positions McKesson (MCK) as a dividend growth stock rather than a high-yield income vehicle. Investors receive regular quarterly distributions that have shown steady increases over time, reflecting the company’s commitment to returning capital while retaining earnings for operations in the healthcare distribution sector.
McKesson (MCK) has demonstrated consistent dividend growth over many years. The company has raised its dividend annually, with recent increases including a 15% hike in the quarterly payout. Historical data shows quarterly dividends progressing from $0.62 in mid-2024 to $0.71 later that year, then to $0.82 in 2025–2026, followed by the announcement of $0.94 for the October 2026 payment. This pattern reflects a multi-year streak of increases, supporting its classification as a reliable dividend growth company. The long-term strategy emphasizes gradual, sustainable raises aligned with earnings expansion in the pharmaceutical and medical supply distribution business.
The dividend appears highly sustainable due to McKesson’s (MCK) low payout ratio of approximately 8%. This figure indicates that only a small portion of earnings is distributed as dividends, leaving substantial room for reinvestment, debt management, or future increases. Free cash flow coverage supports ongoing payments, and the company maintains a stable financial profile typical of large healthcare distributors. Low leverage relative to earnings further bolsters dividend reliability. With such conservative metrics, McKesson (MCK) faces minimal risk of cuts even during economic pressures, positioning the dividend as resilient for long-term holders.
Within the healthcare distribution sector, McKesson’s (MCK) dividend yield of about 0.38% is modest compared to some peers. Companies such as Cardinal Health (CAH) and Cencora (ABC) often offer similar or slightly higher yields, though all remain in the low single digits. McKesson (MCK) stands out for its emphasis on consistent growth and an exceptionally low payout ratio, which may appeal more to growth-oriented investors than those seeking immediate high income. Overall, the dividend profile aligns with industry norms for mature distributors that prioritize balance sheet strength over aggressive distributions.
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore opportunities with the AI Screener.
McKesson (MCK) may suit dividend growth investors seeking long-term compounding through regular increases rather than high current yields. Its low payout ratio and history of annual raises provide a foundation for potential future growth, appealing to conservative, long-term investors who value stability in the healthcare sector. Income-focused investors prioritizing higher yields might find the return insufficient compared to other options. The stock could fit portfolios emphasizing capital appreciation alongside modest dividend income, though suitability depends on individual risk tolerance and time horizon. Investors should evaluate McKesson (MCK) alongside broader portfolio needs without expecting outsized immediate distributions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a distributer of pharmaceuticals and provides healthcare software and health information technology services
Industry MedicalDistributors